Cargando…

Serum Cystatin C Trajectory Is a Marker Associated With Diabetic Kidney Disease

OBJECTIVE: To explore the association of the trajectory of serum Cystatin C (Cysc) with diabetic kidney disease (DKD), a retrospective cohort study of Chinese subjects was carried out. METHOD: A review of 2,928 diabetes mellitus (DM) patients admitted to the clinic and ward of the Endocrinology Depa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Nana, Lu, Zhenyu, Zhang, Wei, Bai, Yu, Pei, Dongmei, Li, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130469/ https://www.ncbi.nlm.nih.gov/pubmed/35634510 http://dx.doi.org/10.3389/fendo.2022.824279

Ejemplares similares

Mendelian randomization study supports the causal association between serum cystatin C and risk of diabetic nephropathy
por: Feng, Baiyu, et al.
Publicado: (2022)

Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes
por: Wong, Chee Wai, et al.
Publicado: (2015)

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Dejenie, Tadesse Asmamaw, et al.
Publicado: (2023)

Serum Cystatin C Levels Are Associated With Obesity in Adolescents Aged 14–17 Years
por: Huo, Ying-Xiang, et al.
Publicado: (2022)

Association Between Serum Cystatin C and Thyroid Diseases: A Systematic Review and Meta-Analysis
por: Xin, Caihong, et al.
Publicado: (2021)

Role of cystatin C in urogenital malignancy
por: Ding, Li, et al.
Publicado: (2022)

Cystatin C: not just a marker of kidney function
por: Fernando, Sanduni, et al.
Publicado: (2020)

Reference Intervals for Serum Cystatin C and Factors Influencing Cystatin C Levels Other than Renal Function in the Elderly
por: Wei, Lu, et al.
Publicado: (2014)

Association Between the Concentration and Rangeability of Cystatin C and Mortality of COVID-19 Patients With or Without Type 2 Diabetes Mellitus: A Retrospective Analysis
por: Yang, Lei, et al.
Publicado: (2021)

Serum Cystatin C – Marker of Inflammation and Cardiovascular Morbidity in Chronic Kidney Disease Stages 1-4
por: Muslimovic, Alma, et al.
Publicado: (2015)

Serum cystatin C as a marker of renal function in detection of early acute kidney injury
por: Murty, M. S. N., et al.
Publicado: (2013)

Association between serum complements and kidney function in patients with diabetic kidney disease
por: Liu, Meng-chao, et al.
Publicado: (2023)

Serum Cystatin C Concentrations in Cats with Hyperthyroidism and Chronic Kidney Disease
por: Williams, T.L., et al.
Publicado: (2016)

White cell count trajectory and type 2 diabetes in health management population: a retrospective cohort study
por: Yang, Tengfei, et al.
Publicado: (2022)

Serum Cystatin C and Arterial Stiffness in Middle-Aged and Elderly Adults without Chronic Kidney Disease: A Population-Based Study
por: Huang, Xiaolin, et al.
Publicado: (2019)

Clinical Usefulness of Serum Cystatin C as a Marker of Renal Function
por: Woo, Kwang-Sook, et al.
Publicado: (2014)

Serum cystatin C concentration as an independent marker for hypertensive left ventricular hypertrophy
por: Li, Xin, et al.
Publicado: (2013)

Cystatin C in pregnant women is not a simple kidney filtration marker
por: Lee, Hajeong
Publicado: (2018)

Estimation of kidney function in patients with primary neuromuscular diseases: is serum cystatin C a better marker of kidney function than creatinine?
por: Aldenbratt, Annika, et al.
Publicado: (2021)

Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease
por: Winter, Lauren, et al.
Publicado: (2018)

Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease
por: Ren, Xuejing, et al.
Publicado: (2023)

A systematic review and meta-analysis of gut microbiota in diabetic kidney disease: Comparisons with diabetes mellitus, non-diabetic kidney disease, and healthy individuals
por: Han, Shisheng, et al.
Publicado: (2022)

Serum Cystatin C as a Biomarker for Early Diabetic Kidney Disease and Dyslipidemia in Young Type 1 Diabetes Patients
por: Stankute, Ingrida, et al.
Publicado: (2022)

The association of plasma cystatin C proteoforms with diabetic chronic kidney disease
por: Yassine, Hussein N., et al.
Publicado: (2016)

Cystatin C Trajectories Among Middle-Aged and Older Americans
por: Zhao, Erfei, et al.
Publicado: (2020)

CD14 and CD26 from serum exosomes are associated with type 2 diabetes, exosomal Cystatin C and CD14 are associated with metabolic syndrome and atherogenic index of plasma
por: Pérez-Macedonio, Claudia Paola, et al.
Publicado: (2022)

Predictive role of serum C-peptide in new-onset renal dysfunction in type 2 diabetes: a longitudinal observational study
por: Sun, Dongmei, et al.
Publicado: (2023)

Epigenetic modification in diabetic kidney disease
por: Liu, Zhe, et al.
Publicado: (2023)

Low Serum Dehydroepiandrosterone Is Associated With Diabetic Kidney Disease in Men With Type 2 Diabetes Mellitus
por: Zhang, Xinxin, et al.
Publicado: (2022)

Cystatin C is Indispensable for Evaluation of Kidney Disease
por: Grubb, Anders
Publicado: (2017)

Cystatin C proteoforms in chronic kidney disease
por: Dahl, Helene, et al.
Publicado: (2023)

Serum cystatin C was a marker of poststroke fatigue in hypertensive intracerebral hemorrhage
por: Yang, Fulan, et al.
Publicado: (2020)

Renal primary cilia lengthen in the progression of diabetic kidney disease
por: Bai, Yunfeng, et al.
Publicado: (2022)

Serum Cystatin C for Evaluation of Acute Kidney Injury in Adults Treated with Colistin
por: Larki, Rozina Abbasi, et al.
Publicado: (2018)

Baseline Serum Cystatin C Is a Potential Predictor for Acute Kidney Injury in Patients with Acute Pancreatitis
por: Chai, Xue, et al.
Publicado: (2018)

Association of Serum 25 (OH) Vitamin D With Chronic Kidney Disease Progression in Type 2 Diabetes
por: Duan, Suyan, et al.
Publicado: (2022)

Serum Cystatin C as a Biomarker for Predicting Coronary Artery Disease in Diabetes
por: Oh, Jee-Young
Publicado: (2010)

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes
por: Krolewski, Andrzej S., et al.
Publicado: (2012)

Association Between High-Sensitivity C-Reactive Protein and Diabetic Kidney Disease in Patients With Type 2 Diabetes Mellitus
por: Tang, Min, et al.
Publicado: (2022)

Risk factors associated with glycated hemoglobin A1c trajectories progressing to type 2 diabetes
por: Halalau, Alexandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7gn5t2kdhm50micp7ekjlvp9l7